Canada - English - Health Canada

sterimax inc - ketamine (ketamine hydrochloride) - solution - 50mg - ketamine (ketamine hydrochloride) 50mg

Australia - English - Department of Health (Therapeutic Goods Administration)

biomed aust pty ltd - ketamine hydrochloride, quantity: 115.3 mg (equivalent: ketamine, qty 100 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - 1. as the sole anaesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation. biomed ketamine is best suited for short procedures and it can be used with additional doses, for longer procedures; 2. for the induction of anaesthesia prior to the administration of other general anaesthetic agents. 3. to supplement low-potency agents, such as nitrous oxide.

Canada - English - Health Canada

sterimax inc - ketamine (ketamine hydrochloride) - solution - 100mg - ketamine (ketamine hydrochloride) 100mg - miscellaneous general anesthetics

Canada - English - Health Canada

sterimax inc - ketamine (ketamine hydrochloride) - solution - 500mg - ketamine (ketamine hydrochloride) 500mg - miscellaneous general anesthetics

United States - English - NLM (National Library of Medicine)

putney, inc. - ketamine hydrochloride (unii: o18yuo0i83) (ketamine - unii:690g0d6v8h) - ketamine 100 mg in 1 ml - ketamine hydrochloride injection, usp may be used in cats for restraint or as the sole anesthetic agent for diagnostic or minor, brief, surgical procedures that do not require skeletal muscle relaxation. it may be used in subhuman primates for restraint. ketamine hydrochloride injection, usp is contraindicated in cats and subhuman primates suffering from renal or hepatic insufficiency. ketamine hydrochloride injection, usp is detoxified by the liver and excreted by the kidneys; therefore, any preexistent hepatic or renal pathology or impairment of function can be expected to result in prolonged anesthesia; related fatalities have been reported.

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - esketamine hydrochloride, quantity: 32.3 mg (equivalent: esketamine, qty 28 mg) - spray, nasal - excipient ingredients: disodium edetate; citric acid monohydrate; water for injections; sodium hydroxide - spravato is indicated for treatment resistant depression (major depressive disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode).,spravato is to be initiated in conjunction with a newly initiated oral antidepressant.

Ireland - English - HPRA (Health Products Regulatory Authority)

sintetica ireland limited - esketamine - solution for injection/infusion - 25 milligram(s)/millilitre - esketamine

Ireland - English - HPRA (Health Products Regulatory Authority)

sintetica ireland limited - esketamine - solution for injection/infusion - 5 milligram(s)/millilitre - esketamine

Ireland - English - HPRA (Health Products Regulatory Authority)

sintetica gmbh - esketamine hydrochloride - solution for injection/infusion - esketamine

Ireland - English - HPRA (Health Products Regulatory Authority)

sintetica gmbh - esketamine hydrochloride - solution for injection/infusion - esketamine